610 related articles for article (PubMed ID: 28819713)
21. Additional Diagnostic Value of Growth Differentiation Factor-15 (GDF-15) to N-Terminal B-Type Natriuretic Peptide (NT-proBNP) in Patients with Different Stages of Heart Failure.
Li J; Cui Y; Huang A; Li Q; Jia W; Liu K; Qi X
Med Sci Monit; 2018 Jul; 24():4992-4999. PubMed ID: 30019695
[TBL] [Abstract][Full Text] [Related]
22. Biomarkers for characterization of heart failure - Distinction of heart failure with preserved and reduced ejection fraction.
Sinning C; Kempf T; Schwarzl M; Lanfermann S; Ojeda F; Schnabel RB; Zengin E; Wild PS; Lackner KJ; Munzel T; Blankenberg S; Wollert KC; Zeller T; Westermann D
Int J Cardiol; 2017 Jan; 227():272-277. PubMed ID: 27838133
[TBL] [Abstract][Full Text] [Related]
23. Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registry.
Chung L; Fairchild RM; Furst DE; Li S; Alkassab F; Bolster MB; Csuka ME; Derk CT; Domsic RT; Fischer A; Frech TM; Gomberg-Maitland M; Gordon JK; Hinchcliff M; Hsu V; Hummers LK; Khanna D; Medsger TAJ; Molitor JA; Preston IR; Schiopu E; Shapiro L; Hant F; Silver R; Simms R; Varga J; Steen VD; Zamanian RT
Clin Exp Rheumatol; 2017; 35 Suppl 106(4):106-113. PubMed ID: 27908301
[TBL] [Abstract][Full Text] [Related]
24. Plasma Connective Tissue Growth Factor as a Biomarker of Pulmonary Arterial Hypertension Associated With Congenital Heart Disease in Adults.
Liu W; Hua Y; Zheng D; Lv W; Zhang W; Chen Q; Huang R; Li X
Circ J; 2023 Mar; 87(4):527-535. PubMed ID: 36843115
[TBL] [Abstract][Full Text] [Related]
25. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803
[TBL] [Abstract][Full Text] [Related]
26. Growth differentiation factor-15 in idiopathic pulmonary arterial hypertension.
Nickel N; Kempf T; Tapken H; Tongers J; Laenger F; Lehmann U; Golpon H; Olsson K; Wilkins MR; Gibbs JS; Hoeper MM; Wollert KC
Am J Respir Crit Care Med; 2008 Sep; 178(5):534-41. PubMed ID: 18565955
[TBL] [Abstract][Full Text] [Related]
27. Soluble neprilysin, NT-proBNP, and growth differentiation factor-15 as biomarkers for heart failure in dialysis patients (SONGBIRD).
Claus R; Berliner D; Bavendiek U; Vodovar N; Lichtinghagen R; David S; Patecki M; Launay JM; Bauersachs J; Haller H; Hiss M; Balzer MS
Clin Res Cardiol; 2020 Aug; 109(8):1035-1047. PubMed ID: 32002632
[TBL] [Abstract][Full Text] [Related]
28. Growth differentiation factor-15 as candidate predictor for mortality in adults with pulmonary hypertension.
Geenen LW; Baggen VJM; Kauling RM; Koudstaal T; Boomars KA; Boersma E; Roos-Hesselink JW; van den Bosch AE
Heart; 2020 Mar; 106(6):467-473. PubMed ID: 31492701
[TBL] [Abstract][Full Text] [Related]
29. Hemodynamic Evaluation of Children with Persistent or Recurrent Pulmonary Arterial Hypertension Following Complete Repair of Congenital Heart Disease.
Latus H; Wagner I; Ostermayer S; Kerst G; Kreuder J; Schranz D; Apitz C
Pediatr Cardiol; 2017 Oct; 38(7):1342-1349. PubMed ID: 28681131
[TBL] [Abstract][Full Text] [Related]
30. Correlation between congenital heart disease complicated with pulmonary artery hypertension and circulating endothelial cells as well as endothelin-1.
Li X; Qiu J; Pan M; Zheng D; Su Y; Wei M; Kong X; Sun W; Zhu J
Int J Clin Exp Pathol; 2015; 8(9):10743-51. PubMed ID: 26617785
[TBL] [Abstract][Full Text] [Related]
31. B-type natriuretic peptide as a parameter for pulmonary hypertension in children. A systematic review.
Ten Kate CA; Tibboel D; Kraemer US
Eur J Pediatr; 2015 Oct; 174(10):1267-75. PubMed ID: 26298682
[TBL] [Abstract][Full Text] [Related]
32. Biological serum markers in the management of pediatric pulmonary arterial hypertension.
Van Albada ME; Loot FG; Fokkema R; Roofthooft MT; Berger RM
Pediatr Res; 2008 Mar; 63(3):321-7. PubMed ID: 18287971
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide, Troponin-T, and Growth-Differentiation Factor 15 in Adult Congenital Heart Disease.
Baggen VJ; van den Bosch AE; Eindhoven JA; Schut AW; Cuypers JA; Witsenburg M; de Waart M; van Schaik RH; Zijlstra F; Boersma E; Roos-Hesselink JW
Circulation; 2017 Jan; 135(3):264-279. PubMed ID: 27832613
[TBL] [Abstract][Full Text] [Related]
34. [The value of brain natriuretic peptide in connective tissue diseases associated with pulmonary arterial hypertension].
Tian Z; Guo XX; Li MT; Wang Q; Liu YT; Zhao JL; Fang Q; Zeng XF
Zhonghua Nei Ke Za Zhi; 2011 Feb; 50(2):102-6. PubMed ID: 21418827
[TBL] [Abstract][Full Text] [Related]
35. Plasma N-terminal pro-brain natriuretic peptide levels are positively correlated with pulmonary arterial pressure in atrial septal defect patients.
Li ZF; Zhou DX; Wang QB; Pan WZ; Zhang L; Ge JB
Regul Pept; 2013 May; 183():13-6. PubMed ID: 23499807
[TBL] [Abstract][Full Text] [Related]
36. The association of the N-terminal pro-brain-type natriuretic peptide response to exercise with disease severity in therapy-naive pulmonary arterial hypertension: a cohort study.
Kutsch J; Faul C; von Scheidt W; Schwaiblmair M; Berghaus TM
Respir Res; 2018 Jan; 19(1):8. PubMed ID: 29334941
[TBL] [Abstract][Full Text] [Related]
37. Iron deficiency in pulmonary arterial hypertension associated with congenital heart disease.
Yu X; Zhang Y; Luo Q; Liu Z; Zhao Z; Zhao Q; Gao L; Jin Q; Yan L
Scand Cardiovasc J; 2018 Dec; 52(6):378-382. PubMed ID: 30632395
[TBL] [Abstract][Full Text] [Related]
38. [Correlation between left ventricular diastolic function and plasma natriuretic peptide level in children with pulmonary artery hypertension secondary to congenital heart disease].
Cui H; Hu YX; Feng ZC
Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jan; 12(1):13-6. PubMed ID: 20113626
[TBL] [Abstract][Full Text] [Related]
39. N-terminal pro-brain natriuretic peptide as a diagnostic marker of early pulmonary artery hypertension in patients with systemic sclerosis and effects of calcium-channel blockers.
Allanore Y; Borderie D; Meune C; Cabanes L; Weber S; Ekindjian OG; Kahan A
Arthritis Rheum; 2003 Dec; 48(12):3503-8. PubMed ID: 14674001
[TBL] [Abstract][Full Text] [Related]
40. B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide in pediatric patients with pulmonary arterial hypertension.
Takatsuki S; Wagner BD; Ivy DD
Congenit Heart Dis; 2012; 7(3):259-67. PubMed ID: 22325151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
